Concepedia

Author

Andrew Maynard

National Cancer Institute

Also Known As

A T Maynard, A. T. MAYNARD, A. T. Maynard, A.T. MAYNARD, A.T. Maynard, A.Yvonne Maynard, Andrew Maynard, Andrew T Maynard, Andrew T. Maynard, Maynard, Andrew

31

Publications

1.6K

Citations

18

H-Index

83

Concepts

All Affiliations

National Cancer InstituteScience Applications International Corporation (United States)Research Triangle Park FoundationGlaxoSmithKline (United States)University of North Carolina at Chapel Hill
AM

About

Andrew Maynard is an author at National Cancer Institute specializing in medicine, natural sciences, and molecular biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

13

1.1K

2

Natural Sciences

7

7

647

3

Engineering

5

5

139

4

Health Sciences

1

1

198

5

Management

1

1

38

Andrew Maynard

×

22

Publications

1.6K

Citations

18

H-Index

YearCitations

Reactivity of the HIV-1 nucleocapsid protein p7 zinc finger domains from the perspective of density-functional theory

Andrew Maynard, Mingjun Huang, William G. Rice,

Proceedings of the National Academy of Sciences

1998

367

Plasma Lipids in Human Linoleic Acid Deficiency

F. D. Collins, Andrew J. Sinclair, J. Royle,

Annals of Nutrition and Metabolism

1971

198

Reactivity of Zinc Finger Cores:  Analysis of Protein Packing and Electrostatic Screening

Andrew Maynard, David G. Covell

Journal of the American Chemical Society

2001

144

Anti-HIV Agents That Selectively Target Retroviral Nucleocapsid Protein Zinc Fingers without Affecting Cellular Zinc Finger Proteins

Mingjun Huang, Andrew Maynard, Jim A. Turpin,

Journal of Medicinal Chemistry

1998

123

Synthesis and Biological Properties of Novel Pyridinioalkanoyl Thiolesters (PATE) as Anti-HIV-1 Agents That Target the Viral Nucleocapsid Protein Zinc Fingers

Jim A. Turpin, Yongsheng Song, John K. Inman,

Journal of Medicinal Chemistry

1998

106

Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor

Lihua Wang, Xiao Yang, Xiaohu Zhang,

Nature Medicine

2003

76

Naturally Occurring CCR5 Extracellular and Transmembrane Domain Variants Affect HIV-1 Co-receptor and Ligand Binding Function

O. M. Zack Howard, Aiko‐Konno Shirakawa, Jim A. Turpin,

Journal of Biological Chemistry

1999

71

Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase

Andrew Maynard, Renae M. Crosby, Byron Ellis,

Journal of Medicinal Chemistry

2013

54

Targeting the NS5A protein of HCV: An emerging option

Daniel G. Cordek, Jill Bechtel, Andrew Maynard,

Drugs of the Future

2011

47

Novel Spiroketal Pyrrolidine GSK2336805 Potently Inhibits Key Hepatitis C Virus Genotype 1b Mutants: From Lead to Clinical Compound

Wieslaw M. Kazmierski, Andrew Maynard, Maosheng Duan,

Journal of Medicinal Chemistry

2014

43

Page 1